Seamus Fernandez

Stock Analyst at Guggenheim

(2.59)
# 555
Out of 5,326 analysts
111
Total ratings
47.27%
Success rate
40.96%
Average return
34 Stocks
Name Action Price Target Current % Upside Ratings Updated
LLY Eli Lilly
Maintains: Buy
973 928
861.09 7.77% 13 Apr 14, 2025
MBX MBX Biosciences
Reiterates: Buy
44 44
9.31 372.61% 2 Apr 10, 2025
ARQT Arcutis Biotherapeut...
Reiterates: Buy
n/a
n/a n/a 3 Apr 3, 2025
VERV Verve Therapeutics
Reiterates: Buy
n/a
n/a n/a 2 Mar 25, 2025
PCVX Vaxcyte
Reiterates: Buy
160 160
34.38 365.39% 4 Mar 12, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
56
21.21 164.03% 1 Feb 25, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
n/a
n/a n/a 2 Feb 24, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
n/a
n/a n/a 7 Feb 10, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
33
21.46 53.77% 1 Nov 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
137 130
79.95 62.6% 11 Nov 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Oct 31, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
70
62.89 11.31% 1 Oct 21, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
16
5.77 177.3% 1 Oct 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 1 Aug 12, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 3 Jul 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 3 Apr 29, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Jan 2, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
20
n/a n/a 1 Aug 11, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
n/a
n/a n/a 2 Jul 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
50
23.65 111.42% 1 Feb 28, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Jan 11, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
65
n/a n/a 1 Nov 15, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 8 Oct 10, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
n/a
n/a n/a 2 May 31, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Dec 15, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 6 Feb 25, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 1 Feb 3, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
48 75
n/a n/a 5 Dec 4, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
27
n/a n/a 3 Nov 15, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
220
n/a n/a 6 Nov 13, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
56 54
1.27 4151.97% 1 Mar 13, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Perform
60 45
19.62 129.36% 2 Mar 8, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Perform
36 38
69.55 -45.36% 6 Feb 6, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Perform
35 38
22.8 66.67% 3 Jan 31, 2018